Answers are grounded in this paper and cite their sources.
Purpose: To develop and validate a fully automated pipeline that measures skeletal muscle and adipose tissue at L1 and L3 on routine CT with varied scan ranges, slice orders and contrast phases, rejects levels outside the scan and converts measures to non-contrast equivalents. Materials and methods: The pipeline (sarco) combines orientation detection, L1/L3 localisation with out-of-range rejection, U-Net segmentation, six-class contrast-phase estimation, phase-specific conversion to non-contrast-equivalent values and, as an auxiliary output, muscle and marrow age estimation. We evaluated it on five single-centre datasets (4986 series): agreement with radiologist-corrected labels using five-fold cross-fitting (2025 series), artificially truncated scans, contrast-enhanced series paired with non-contrast series of the same examination, and the prognostic value of fully automated measures in 2006 patients after curative cancer surgery. TotalSegmentator served as a comparator. Results: On held-out folds, L3 skeletal muscle area (SMA) agreed with the reference (intraclass correlation coefficient 0.983; bias +1.35 cm2). On truncated scans processed with cross-fitted localisation models, the chosen L3 slice was off by half a vertebra or more in 4.7-5.6% of volumes (TotalSegmentator 11.3-14.3%). Four-group phase accuracy was 0.949, exceeding TotalSegmentator in scans shorter than 400 mm (0.952-0.960 vs 0.643-0.668), and conversion reduced the root mean square error of L3 muscle attenuation against the same-examination non-contrast series from 7.96 to 2.81 HU. Combined age estimates had a mean absolute error of 6.5 years. Automatically measured low muscle mass increased the cross-validated Uno's C of the baseline model by 0.034 (95% CI 0.009-0.053; cancer-specific survival) and 0.031 (0.016-0.048; overall survival), whereas converted L3 muscle attenuation added 0.012 (-0.005 to 0.024) for overall survival. Conclusion: The pipeline provides robust, contrast-phase-aware body composition measures from routine CT with varied scan ranges and reproduces known prognostic associations without manual input.
No takes yet. Share an insight, caveat, or question.
Hanaoka et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: